TriangleNCT00309842 · OUTCOME
Number of Participants Who Were Alive at 1 Year Transplant Overall Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- at 1 year
What was measured
Number of patients alive at 1 year after transplant.
Groups in this outcome
Unrelated UCBT for Blood Cancers
Patients undergoing unrelated umbilical cord blood transplantation (UCBT) for hematologic malignancies treated with myeloablative preparative regimen comprising fludarabine phosphate, mycophenolate mofetil, filgrastim, cyclophosphamide, cyclosporine and fractionated total-body irradiation.
| Group | Source count |
|---|---|
| Unrelated UCBT for Blood Cancers | 212 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Unrelated UCBT for Blood Cancers | 130 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 130
- denoms
- counts
- group Id
- OG000
- value
- 212
- units
- Participants
- description
- Number of patients alive at 1 year after transplant.
- groups
- description
- Patients undergoing unrelated umbilical cord blood transplantation (UCBT) for hematologic malignancies treated with myeloablative preparative regimen comprising fludarabine phosphate, mycophenolate mofetil, filgrastim, cyclophosphamide, cyclosporine and fractionated total-body irradiation.
- id
- OG000
- title
- Unrelated UCBT for Blood Cancers
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- at 1 year
- title
- Number of Participants Who Were Alive at 1 Year Transplant Overall Survival
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice